Provided by Tiger Trade Technology Pte. Ltd.

Ironwood Pharmaceuticals

4.29
+0.15003.62%
Post-market: 4.340.0500+1.17%19:46 EDT
Volume:2.27M
Turnover:9.70M
Market Cap:706.19M
PE:5.44
High:4.30
Open:4.22
Low:4.19
Close:4.14
52wk High:5.78
52wk Low:1.01
Shares:164.61M
Float Shares:136.00M
Volume Ratio:1.41
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7890
EPS(LYR):0.1484
ROE:-574.72%
ROA:47.02%
PB:-4.36
PE(LYR):28.91

Loading ...

Jun 30, 2023

Major Issues Report

Form 8-K - Current report
Jun 23, 2023

Major Issues Report

Form 8-K - Current report
Jun 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 23, 2023

Major Issues Report

Form 8-K - Current report
May 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 08, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2023

Major Issues Report

8-K - Current report
Apr 11, 2023

Major Issues Report

8-K - Current report
Feb 16, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Nov 03, 2022

Major Issues Report

8-K - Current report